Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ROSUVASTATIN CALCIUM USP, with a corresponding US DMF Number 31291.
Remarkably, this DMF maintains an Active status since its submission on May 04, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 22, 2017, and payment made on January 05, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II